RESIDENT'S FORUM
RF—Electrochemotherapy in the Treatment of Primary and Secondary Skin Tumors
FR—Electroquimioterapia para el tratamiento de tumores cutáneos primarios y secundarios
D. Vega Díez
, A. Rodríguez-Villa Lario, L. Trasobares Marugán
Autor para correspondencia
Servicio de Dermatología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
Leído
2863
Vecesse ha leído el artículo
1098
Total PDF
1765
Total HTML
Compartir estadísticas
array:25 [ "pii" => "S0001731022006135" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.05.031" "estado" => "S300" "fechaPublicacion" => "2022-09-01" "aid" => "3120" "copyright" => "AEDV" "copyrightAnyo" => "2021" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2022;113:T817-T818" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S0001731022003027" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.01.037" "estado" => "S300" "fechaPublicacion" => "2022-09-01" "aid" => "3018" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113:819-20" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Practical Dermoscopy</span>" "titulo" => "Dermoscopy for the Diagnosis of Palmar Lichen Nitidus" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "819" "paginaFinal" => "820" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Dermatoscopia para el diagnóstico de liquen nítido palmar" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 997 "Ancho" => 900 "Tamanyo" => 340500 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Light microscopy image shows parakeratosis and supra-papillary thinning. Rete ridges are elongated and acanthotic, enclosing lymphohistiocytic infiltrate and dilated capillaries. (hematoxylin–eosin, original magnification ×10).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "P. Jayasree, F. Kaliyadan, K.T. Ashique" "autores" => array:3 [ 0 => array:2 [ "nombre" => "P." "apellidos" => "Jayasree" ] 1 => array:2 [ "nombre" => "F." "apellidos" => "Kaliyadan" ] 2 => array:2 [ "nombre" => "K.T." "apellidos" => "Ashique" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022003027?idApp=UINPBA000044" "url" => "/00017310/0000011300000008/v1_202208290519/S0001731022003027/v1_202208290519/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0001731021004579" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.05.019" "estado" => "S300" "fechaPublicacion" => "2022-09-01" "aid" => "2846" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2022;113:817-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Foro de Residentes</span>" "titulo" => "FR- Electroquimioterapia para el tratamiento de tumores cutáneos primarios y secundarios" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "817" "paginaFinal" => "818" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "RF- Electrochemotherapy in the Treatment of Primary and Secondary Skin Tumors" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "D. Vega Díez, A. Rodríguez-Villa Lario, L. Trasobares Marugán" "autores" => array:3 [ 0 => array:2 [ "nombre" => "D." "apellidos" => "Vega Díez" ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Rodríguez-Villa Lario" ] 2 => array:2 [ "nombre" => "L." "apellidos" => "Trasobares Marugán" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021004579?idApp=UINPBA000044" "url" => "/00017310/0000011300000008/v1_202208290519/S0001731021004579/v1_202208290519/es/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S0001731021004579" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.05.019" "estado" => "S300" "fechaPublicacion" => "2022-09-01" "aid" => "2846" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2022;113:817-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Foro de Residentes</span>" "titulo" => "FR- Electroquimioterapia para el tratamiento de tumores cutáneos primarios y secundarios" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "817" "paginaFinal" => "818" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "RF- Electrochemotherapy in the Treatment of Primary and Secondary Skin Tumors" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "D. Vega Díez, A. Rodríguez-Villa Lario, L. Trasobares Marugán" "autores" => array:3 [ 0 => array:2 [ "nombre" => "D." "apellidos" => "Vega Díez" ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Rodríguez-Villa Lario" ] 2 => array:2 [ "nombre" => "L." "apellidos" => "Trasobares Marugán" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021004579?idApp=UINPBA000044" "url" => "/00017310/0000011300000008/v1_202208290519/S0001731021004579/v1_202208290519/es/main.assets" ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">RESIDENT'S FORUM</span>" "titulo" => " RF—Electrochemotherapy in the Treatment of Primary and Secondary Skin Tumors" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "T817" "paginaFinal" => "T818" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "D. Vega Díez, A. Rodríguez-Villa Lario, L. Trasobares Marugán" "autores" => array:3 [ 0 => array:4 [ "nombre" => "D." "apellidos" => "Vega Díez" "email" => array:1 [ 0 => "david.vg10@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Rodríguez-Villa Lario" ] 2 => array:2 [ "nombre" => "L." "apellidos" => "Trasobares Marugán" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Dermatología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "FR—Electroquimioterapia para el tratamiento de tumores cutáneos primarios y secundarios" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Electrochemotherapy (ECT) is a technique for the treatment of primary and secondary skin tumors based on the use of low-dose chemotherapy combined with pulsed application of high-intensity electric fields, causing reversible permeabilization of the cell membrane and thereby increasing the penetration of chemotherapeutic agents (bleomycin and, less frequently, cisplatin). It is currently an option included in the treatment guidelines for cutaneous squamous cell carcinoma (cSCC), basal cell carcinoma (BCC), melanoma, Kaposi sarcoma (KS) and soft tissue sarcoma, Merkel cell carcinoma, and skin metastasis of non-cutaneous neoplasms.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a> The main advantages of this technique are its simplicity, versatility, efficacy, and tolerability, its few significant adverse effects, and its utility in frail patients.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Clover et al.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> recently presented the results of the Pan-European International Network for Sharing Practice in Electrochemotherapy. Here, we present their results obtained in a population of 987 patients with various skin tumors treated with ECT. Melanoma was the most frequently treated tumor (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>283; 29%) followed by CBC (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>298; 30%). Of the 987 patients, 61% showed a complete response (CR), 22% showed a partial response (PR), 12% achieved disease stabilization, and 3% experienced disease progression. By histological type, the best responses were obtained for KS (CR, 91%) with an overall response (OR, defined as CR and PR) of 98%, followed by BCC (CR, 85%; OR, 96%), melanoma (CR, 64%; OR, 82%), skin metastasis of breast cancer (CR, 62%; OR, 77%), and cSCC (CR, 63%; OR, 80%). Other factors associated with greater efficacy were smaller tumor size (CR, 82% in lesions<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>5<span class="elsevierStyleHsp" style=""></span>mm and 35% in lesions >10<span class="elsevierStyleHsp" style=""></span>cm) and intravenous (versus intralesional) administration in lesions >2<span class="elsevierStyleHsp" style=""></span>cm, while lower efficacy was observed in previously irradiated tissues (CR, 59% vs 71%).</p><p id="par0015" class="elsevierStylePara elsevierViewall">The high CR rates obtained in KS (which were similar to those reported in the literature), together with ECT's excellent safety and tolerability profile, make it a very interesting option for patients with multiple SK lesions,<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> and for those with BCC in whom other options have failed or are not possible. In melanoma, ECT is primarily used for the treatment of symptomatic cutaneous metastases (OR, 50–80% depending on the series consulted). However, given its mode of action (induction of immunogenic cell death<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a>), studies are investigating the efficacy in melanoma of ECT combined with immunomodulatory agents, based on the premise that ECT could enhance the local immune action of immunomodulatory agents to achieve a systemic antitumor immune response (an effect already demonstrated in mouse models<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a>). However, to date the only available data on the combination of ECT with ipilumab and PD-1 inhibitors come from case reports and small patient series, which have demonstrated variable, albeit promising, results. Results from larger, ongoing studies are pending.</p><p id="par0020" class="elsevierStylePara elsevierViewall">For these reasons, ECT should be included among the therapeutic options offered to our patients, in the context of a multidisciplinary decision-making process.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1550955" "palabras" => array:6 [ 0 => "Electrochemotherapy" 1 => "Bleomycin" 2 => "Melanoma" 3 => "Cutaneous squamous cell carcinoma" 4 => "Kaposi sarcoma" 5 => "Skin cancer" ] ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Electrochemotherapy of superficial tumors – current status: basic principles, operating procedures, shared indications, and emerging applications" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L.G. Campana" 1 => "D. Miklavčič" 2 => "G. Bertino" 3 => "R. Marconato" 4 => "S. Valpione" 5 => "I. Imarisio" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.seminoncol.2019.04.002" "Revista" => array:6 [ "tituloSerie" => "Semin Oncol" "fecha" => "2019" "volumen" => "46" "paginaInicial" => "173" "paginaFinal" => "191" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31122761" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.J.P. Clover" 1 => "F. de Terlizzi" 2 => "G. Bertino" 3 => "P. Curatolo" 4 => "J. Odili" 5 => "L.G. Campana" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ejca.2020.06.020" "Revista" => array:6 [ "tituloSerie" => "Eur J Cancer" "fecha" => "2020" "volumen" => "138" "paginaInicial" => "30" "paginaFinal" => "40" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32836172" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Electrochemotherapy as “new standard of care” treatment for cutaneous Kaposi's sarcoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Di Monta" 1 => "C. Caracò" 2 => "L. Benedetto" 3 => "S. La Padula" 4 => "U. Marone" 5 => "M.L. Tornesello" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ejso.2013.09.002" "Revista" => array:6 [ "tituloSerie" => "Eur J Surg Oncol" "fecha" => "2014" "volumen" => "40" "paginaInicial" => "61" "paginaFinal" => "66" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24075826" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.Y. Calvet" 1 => "D. Famin" 2 => "F.M. André" 3 => "L.M. Mir" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4161/onci.28131" "Revista" => array:5 [ "tituloSerie" => "Oncoimmunology" "fecha" => "2014" "volumen" => "3" "paginaInicial" => "e28131" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25083316" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The use of electrochemotherapy in combination with immunotherapy in the treatment of metastatic melanoma: a focused review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C.A. Goggins" 1 => "A. Khachemoune" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ijd.14314" "Revista" => array:6 [ "tituloSerie" => "Int J Dermatol" "fecha" => "2019" "volumen" => "58" "paginaInicial" => "865" "paginaFinal" => "870" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30479009" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00017310/0000011300000008/v1_202208290519/S0001731022006135/v1_202208290519/en/main.assets" "Apartado" => array:4 [ "identificador" => "83195" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Foro de Residentes" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011300000008/v1_202208290519/S0001731022006135/v1_202208290519/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022006135?idApp=UINPBA000044" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 13 | 21 | 34 |
| 2024 Octubre | 104 | 52 | 156 |
| 2024 Septiembre | 105 | 45 | 150 |
| 2024 Agosto | 123 | 78 | 201 |
| 2024 Julio | 87 | 46 | 133 |
| 2024 Junio | 96 | 38 | 134 |
| 2024 Mayo | 76 | 43 | 119 |
| 2024 Abril | 67 | 26 | 93 |
| 2024 Marzo | 68 | 46 | 114 |
| 2024 Febrero | 49 | 36 | 85 |
| 2024 Enero | 33 | 29 | 62 |
| 2023 Diciembre | 35 | 9 | 44 |
| 2023 Noviembre | 43 | 40 | 83 |
| 2023 Octubre | 45 | 25 | 70 |
| 2023 Septiembre | 37 | 31 | 68 |
| 2023 Agosto | 39 | 18 | 57 |
| 2023 Julio | 46 | 36 | 82 |
| 2023 Junio | 47 | 21 | 68 |
| 2023 Mayo | 40 | 24 | 64 |
| 2023 Abril | 24 | 17 | 41 |
| 2023 Marzo | 39 | 28 | 67 |
| 2023 Febrero | 43 | 19 | 62 |
| 2023 Enero | 50 | 50 | 100 |
| 2022 Diciembre | 55 | 43 | 98 |
| 2022 Noviembre | 60 | 37 | 97 |
| 2022 Octubre | 56 | 44 | 100 |
| 2022 Septiembre | 144 | 84 | 228 |
| 2022 Agosto | 77 | 60 | 137 |
| 2022 Julio | 64 | 52 | 116 |
Mostrar todo
